Fig. 2From: Real-world efficiency of lenvatinib plus PD-1 blockades in advanced hepatocellular carcinoma: an exploration for expanded indicationsThe survival curves of HCC patients with and without tumor thrombosis in Vp4. There was no significant difference between HCC patients with and without Vp4 invasion in terms of PFS (A) and OS (B) (p = 0.528 and 0.855)Back to article page